Skip to content Skip to footer
Pharma Mart Group

Business Units

Close

Treatment of acutely decompensated severe chronic heart failure (ADHF)

✓ Enhances the calcium sensitivity of contractile proteins by binding to cardiac troponin C in a calcium-dependent manner
✓ Increases the contraction force but does not impair ventricular relaxation
✓ Levosimendan opens ATP-sensitive potassium channels in vascular smooth muscle

Dosage Form: Concentrate for Solution for Infusion
Size: 5ml Vial

Category: Product ID: 422

Description

Share on :

Ingredients

Levosimendan 2.5mg/ml

Indications

Short-term treatment of acutely decompensated severe chronic heart failure (ADHF) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate